US Broker Ratings

Semler Scientific, Inc. (SMLR) Stock Analysis: A Healthcare Gem with 255% Potential Upside

Semler Scientific, Inc. (NASDAQ: SMLR) is capturing investor attention with its significant potential upside, as indicated by a robust analyst target price range. Despite recent challenges,..

Butterfly Network, Inc. (BFLY) Stock Analysis: Evaluating a Potential 68.82% Upside

Butterfly Network, Inc. (BFLY), a player in the healthcare sector specializing in medical devices, has been capturing investor attention with its innovative ultrasound imaging solutions. With..

CeriBell, Inc. (CBLL) Stock Analysis: Unveiling an 81% Potential Upside

CeriBell, Inc. (CBLL) is making waves in the healthcare sector with its innovative approach to addressing neurological conditions. As a medical technology company, CeriBell is pioneering..

Community Health Systems, Inc. (CYH) Stock Analysis: Navigating a 32.9% Potential Upside Amid Challenges

Community Health Systems, Inc. (CYH) operates at the heart of the U.S. healthcare sector, running a network of general acute care hospitals that provide a broad..

Valneva SE (VALN) Stock Analysis: Exploring a 36.62% Potential Upside in the Booming Biotech Sector

Valneva SE (VALN), a French biotechnology company, has rapidly emerged as a key player in the healthcare sector with its innovative approach to vaccines. Specializing in..

Altimmune, Inc. (ALT) Stock Analysis: Unveiling a 270% Potential Upside in Biotech

Altimmune, Inc. (NASDAQ: ALT) has captured the attention of investors with its compelling narrative and significant potential upside. As a clinical-stage biopharmaceutical company, Altimmune is primarily..

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: High Growth Potential with a 96% Upside

ArriVent BioPharma, Inc. (NASDAQ: AVBP) stands as a promising player in the biotechnology sector, catching the attention of investors with its high-growth potential and a substantial..

Arbutus Biopharma Corporation (ABUS) Stock Analysis: Exploring 33.73% Potential Upside in Biotech

Arbutus Biopharma Corporation (NASDAQ: ABUS), a clinical-stage biopharmaceutical company, is making waves in the biotechnology industry with a promising pipeline targeting chronic Hepatitis B virus (HBV)...

Immatics N.V. (IMTX) Stock Analysis: A Biotech Powerhouse with 75% Upside Potential

Immatics N.V. (NASDAQ: IMTX), a promising player in the biotechnology sector, has captured the attention of investors with its innovative approach to cancer treatment. With a..

Cullinan Therapeutics, Inc. (CGEM) Investor Outlook: Biotechnology Innovator with a 199% Potential Upside

Cullinan Therapeutics, Inc. (CGEM) is capturing investor attention with its promising potential upside of 199.44%, as suggested by the average target price set by analysts. As..

STAAR Surgical Company (STAA) Stock Analysis: Navigating Growth with a 90.17 Forward P/E

STAAR Surgical Company (NASDAQ: STAA), a key player in the medical instruments and supplies industry, is an intriguing prospect for investors, particularly due to its focus..

REGENXBIO Inc. (RGNX) Stock Analysis: Unpacking the 171.81% Upside Potential

Investors seeking opportunities in the biotechnology space may want to keep an eye on REGENXBIO Inc. (NASDAQ: RGNX), a company that is making waves with its..

Bicycle Therapeutics plc (BCYC) Stock Analysis: Exploring a 254.94% Potential Upside

Bicycle Therapeutics plc (NASDAQ: BCYC), a clinical-stage biotechnology firm based in Cambridge, UK, is making waves in the healthcare sector with its innovative approach to developing..

Stoke Therapeutics, Inc. (STOK) Stock Analysis: A Promising Biotech with a 13.23% Upside Potential

Stoke Therapeutics, Inc. (NASDAQ: STOK), a notable player in the biotechnology sector, is capturing investor attention with its robust growth potential and a focus on innovative..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: Uncovering a Potential 94.52% Upside in the Biotech Sector

Enliven Therapeutics, Inc. (NASDAQ: ELVN) has been garnering attention in the healthcare sector, particularly within the biotechnology industry. Based in Boulder, Colorado, this innovative biopharmaceutical company..

Nutex Health Inc. (NUTX) Stock Analysis: Exploring a 69.78% Potential Upside in the Dynamic Healthcare Sector

Nutex Health Inc. (NUTX) is making waves in the healthcare sector, with a market capitalization of $1.01 billion and a robust presence across the United States...

Xencor, Inc. (XNCR)

⚠️ No article content returned.

..

Xeris Biopharma Holdings, Inc. (XERS) Stock Analysis: Exploring a Promising 68% Upside for Investors

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) is catching the eye of investors with its promising potential upside of 68.13%, according to recent analyst ratings. The Chicago-based..

Neuropace, Inc. (NPCE) Stock Analysis: A Look at its 29.63% Potential Upside and Robust Revenue Growth

For investors with a keen eye on the healthcare sector, Neuropace, Inc. (NASDAQ: NPCE) offers an intriguing opportunity within the medical devices industry. Known for its..

Nuvation Bio (NUVB) Stock Analysis: Exploring a 44.69% Upside Potential in the Biotech Arena

Nuvation Bio Inc. (NASDAQ: NUVB) presents a compelling opportunity for investors eyeing growth in the biotechnology sector. With a market capitalization of $2.4 billion, this clinical-stage..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds